New findings on the structure-phototoxicity relationship and photostability of fluoroquinolones

Yakugaku Zasshi

Volumn 125, Issue 3, 2005, Pages 255-261

  Hayashi, Norihiro ^a  

^a WAKUNAGA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Fluoroquinolone; Photostability; Phototoxicity

Indexed keywords

1 AMINODIFLUOROPHENYL 8 CHLOROQUINOLONE; 1 DIFLUOROPHENYL 8 CHLOROQUINOLONE; 7 (3 AMINOPYRROLIDINYL)QUINOLONE; CIPROFLOXACIN; CLINAFLOXACIN; FLEROXACIN; GATIFLOXACIN; HALOGEN; LEVOFLOXACIN; LOMEFLOXACIN; MOXIFLOXACIN; NORFLOXACIN; QUINOLONE DERIVATIVE; SPARFLOXACIN; TOSUFLOXACIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ATOM; CONTROLLED STUDY; DRUG STRUCTURE; EXTERNAL EAR; MOUSE; NONHUMAN; PHOTODEGRADATION; PHOTOTOXICITY; REACTION TIME; REVIEW; STRUCTURE ANALYSIS; ULTRAVIOLET RADIATION;

ANIMALS; DERMATITIS, PHOTOTOXIC; DRUG DESIGN; DRUG STABILITY; FLUOROQUINOLONES; MICE; STRUCTURE-ACTIVITY RELATIONSHIP; ULTRAVIOLET RAYS;

EID: 18244408539     PISSN: 00316903     EISSN: None     Source Type: Journal    
DOI: 10.1248/yakushi.125.255     Document Type: Review

References (22)

1. Domagala J. M., J. Antimicrob. Chemother., 33, 685-706 (1994).
2. Sanchez J. P., Gogliotii R. D., Domagala J. M., Gracheck S. J., Huband M. D., Sesnie J. A., Cohen M. A., Shapiro M. A., J. Med. Chem., 38, 4478-4487 (1995).
3. Klaassen C. D., "The Pharmacological Basis of Therapeutics," 10th ed. McGraw-Hill., 2001, pp. 67-80.
4. Arata J., Horio T., Soejima R., Ohara K., Antimicrob. Agents Chemother., 42, 3141-3145 (1998).
5. Blondeau J. M., Clin. Therapeutics, 21, 3-40 (1999).
6. Ferguson J., Photochem. Photobiol., 62, 954-958 (1995).
7. Horio T., Miyauchi H., Asada Y., Aoki Y., Harada M., J. Dermatol. Sci., 1, 130-135 (1994).
8. Oliveira H. S., Goncalo M., Figueiredo A. C., Photodermatol. Photoimmunol. Photomed., 16, 116-120 (2000).
9. Martinez L. J., Li G., Chignell C. F., Photochem. Photobiol., 65, 599-602 (1997).
10. Matsumoto M., Kojima K., Nagano H., Matsubara S., Yokota T., Antimicrob. Agents Chemother., 36, 1715-1719 (1992).
11. Morimura T., Ohno T., Matsukura H., Nobuhara Y., Chem. Pharm. Bull., 43, 1000-1004 (1995).
12. Ferguson J., Johnson B. E., Br. J. Dermatol., 123, 9-20 (1990).
13. Vousden M., Ferguson J., Richards J., Bird N., Allen A., Chemotherapy, 45, 512-520 (1999).
14. Iwamoto Y., Kurita A., Shimizu T., Masuzawa T., Uno K., Yagi M., Kitagawa T., Oku T., Yanagihara Y., Biol. Pharm. Bull., 17, 654-657 (1994).
15. Hayashi N., Amano H., Ohshita Y., Niino Y., Yoshida J., Yazaki A., 36th Intersci. Conf. Antimicrob. Agents Chemother., abstr. F051, New Orleans, 1996.
16. Kuramoto Y., Ohshita Y., Yoshida J., Yazaki A., Shiro M., Koike T., J. Med. Chem., 46, 1905-1917 (2003).
17. Marutani K., Matsumoto M., Otabe Y., Nagamuta M., Tanaka K., Miyoshi A., Hasegawa T., Nagano H., Matsubara S., Kamide R., Yokota T., Matsumoto F., Ueda Y., Antimicrob. Agents Chemother., 37, 2217-2223 (1993).
18. Wagai N., Yamaguchi F., Sekiguchi M., Tawara K., Toxicol. Lett., 54, 299-308 (1990).
19. Wagai N., Tawara K., Toxicol. Lett., 58, 215-223 (1991).
20. Fass R. J., Antimicrob. Agents Chemother., 37, 2348-2357 (1993).
21. Fass R. J., Antimicrob. Agents Chemother., 41, 1818-1824 (1997).
22. Araki T., Kawai I., Ohta I., Kitaoka H., Chem. Pharm. Bull., 50, 229-234 (2002).